{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:12:40Z","timestamp":1790716360027,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81760284"],"award-info":[{"award-number":["81760284"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20192BCD40003"],"award-info":[{"award-number":["20192BCD40003"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.heliyon.2024.e37523","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T17:40:35Z","timestamp":1725644435000},"page":"e37523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Chlorogenic acid exhibits antitumor effect in patient-derived xenograft models and hydrogel-embedded tissue culture drug susceptibility test of tongue cancer"],"prefix":"10.1016","volume":"10","author":[{"given":"Jia","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqiao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3596-9562","authenticated-orcid":false,"given":"Xiaoping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.heliyon.2024.e37523_bib1","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1177\/0194599813477992","article-title":"Distinct epidemiologic characteristics of oral tongue cancer patients","volume":"148","author":"Li","year":"2013","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.heliyon.2024.e37523_bib2","first-page":"115","article-title":"Survival outcomes after treatment of cancer of the oral cavity (1985-2015), Oral","volume":"90","author":"Zanoni","year":"2019","journal-title":"Oncol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e37523_bib3","article-title":"Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy","volume":"12","author":"Parmar","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7782","key":"10.1016\/j.heliyon.2024.e37523_bib4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37523_bib5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/hed.23380","article-title":"Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer, Head","volume":"36","author":"Almangush","year":"2014","journal-title":"Neck."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e37523_bib6","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.oraloncology.2010.06.006","article-title":"Prognostic evaluation of oral tongue cancer: means, markers and perspectives (I)","volume":"46","author":"Bello","year":"2010","journal-title":"Oral Oncol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37523_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbcan.2018.06.004","article-title":"Preclinical models for precision oncology","volume":"1870","author":"Ibarrola-Villava","year":"2018","journal-title":"Biochim. Biophys. Acta. Rev. Cancer."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37523_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.14348\/molcells.2016.2350","article-title":"An Integrative approach to precision cancer medicine using patient-derived xenografts","volume":"39","author":"Cho","year":"2016","journal-title":"Mol. Cells."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37523_bib9","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrclinonc.2012.61","article-title":"Patient-derived tumour xenografts as models for oncology drug development","volume":"9","author":"Tentler","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e37523_bib10","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.1007\/s00432-023-04618-0","article-title":"Selinexor demonstrates anti-tumor efficacy in paired patient-derived xenograft models and hydrogel-embedded histoculture drug sensitivity test of penile cancer","volume":"149","author":"He","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37523_bib11","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1111\/1541-4337.12620","article-title":"A comprehensive review of the dietary sources, processing effects, bioavailability, beneficial properties, mechanisms of action, and future directions","volume":"19","author":"Lu","year":"2020","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"10.1016\/j.heliyon.2024.e37523_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106505","article-title":"Chlorogenic acid for cancer prevention and therapy: current status on efficacy and mechanisms of action","volume":"186","author":"Gupta","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.heliyon.2024.e37523_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110673","article-title":"Chlorogenic acid inhibits the proliferation of human lung cancer A549 cell lines by targeting annexin A2 in vitro and in vivo","volume":"131","author":"Wang","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"1\u20133","key":"10.1016\/j.heliyon.2024.e37523_bib14","first-page":"229","article-title":"Inhibitory effects of chlorogenic acid and its related compounds on the invasion of hepatoma cells in culture","volume":"33","author":"Yagasaki","year":"2020","journal-title":"Cytotechnology"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37523_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22642","article-title":"Chlorogenic acid induces 4T1 breast cancer tumor's apoptosis via p53, Bax, Bcl-2, and caspase-3 signaling pathways in BALB\/c mice","volume":"35","author":"Changizi","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"16","key":"10.1016\/j.heliyon.2024.e37523_bib16","doi-asserted-by":"crossref","first-page":"8586","DOI":"10.3390\/ijms22168586","article-title":"Chlorogenic acid enhances doxorubicin-mediated cytotoxic effect in osteosarcoma cells","volume":"22","author":"Salzillo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e37523_bib17","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.1007\/s00432-023-04618-0","article-title":"Selinexor demonstrates anti-tumor efficacy in paired patient-derived xenograft models and hydrogel-embedded histoculture drug sensitivity test of penile cancer","volume":"149","author":"He","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e37523_bib18","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.21873\/anticanres.15450","article-title":"Applicability of the histoculture drug response assay to predict platinum sensitivity and prognosis in ovarian cancer","volume":"41","author":"Lee","year":"2021","journal-title":"Anticancer. Research."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e37523_bib19","first-page":"1537","article-title":"Potential of the histoculture drug-response assay to contribute to cancer patient survival","volume":"1","author":"Kubota","year":"1995","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37523_bib20","first-page":"795","article-title":"Effect of HDST technology in neoadjuvant chemotherapy for ovarian cancer","volume":"41","author":"Rao","year":"2020","journal-title":"Journal. Of. Sun. Yat.-sen. University. (Medical. Sciences)"},{"issue":"19","key":"10.1016\/j.heliyon.2024.e37523_bib21","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1016\/j.yexcr.2006.08.019","article-title":"Immunodeficient mice have elevated numbers of NK cells in non-lymphoid tissues","volume":"312","author":"Grundy","year":"2006","journal-title":"Exp. Cell Res."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e37523_bib22","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.3390\/s18103249","article-title":"Matrix metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: recent advances","volume":"18","author":"Huang","year":"2018","journal-title":"Sensors"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37523_bib23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13046-020-01709-5","article-title":"The role of microenvironment in tumor angiogenesis","volume":"39","author":"Jiang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37523_bib24","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s12885-020-06786-5","article-title":"Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer","volume":"20","author":"Kang","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.heliyon.2024.e37523_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.153909","article-title":"Clear cell squamous cell carcinoma of the tongue exhibits characteristics as an undifferentiated squamous cell carcinoma","volume":"235","author":"Hasegawa","year":"2022","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37523_bib26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ygyno.2019.11.020","article-title":"Patient-derived explants, xenografts and organoids: 3-dimensional patient-relevant pre-clinical models in endometrial cancer","volume":"156","author":"Collins","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.heliyon.2024.e37523_bib27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biomaterials.2017.01.030","article-title":"Biomechanically primed liver microtumor array as a high-throughput mechanopharmacological screening platform for stroma-reprogrammed combinatorial therapy","volume":"124","author":"Zhu","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.heliyon.2024.e37523_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11010-017-3171-1","article-title":"Chlorogenic acid regulates apoptosis and stem cell marker-related gene expression in A549 human lung cancer cells","volume":"441","author":"Yamagata","year":"2018","journal-title":"Mol. Cell. Biochem."},{"issue":"30","key":"10.1016\/j.heliyon.2024.e37523_bib29","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00216-017-0657-3","article-title":"Isolation and identification of human metabolites from a novel anti-tumor candidate drug 5-chlorogenic acid injection by HPLC-HRMS\/MSn and HPLC-SPE-NMR","volume":"409","author":"Ren","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37523_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101294","article-title":"Chlorogenic acid: potential source of natural drugs for the therapeutics of fibrosis and cancer","volume":"15","author":"Nwafor","year":"2022","journal-title":"Transl. Oncol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37523_bib31","first-page":"855","article-title":"Chlorogenic acid regulates the proliferation and migration of high-grade serous ovarian cancer cells through modulating the miR199a5p\/DDR1 axis","volume":"69","author":"Wang","year":"2022","journal-title":"Acta Biochim. Pol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37523_bib32","first-page":"717","article-title":"Chlorogenic acid induces apoptosis, inhibits metastasis and improves antitumor immunity in breast cancer via the NF-\u03baB signaling pathway, Oncol","volume":"45","author":"Zeng","year":"2021","journal-title":"Rep."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37523_bib33","first-page":"257","article-title":"Double immunofluorescence labeling for CD31 and CD105 as a marker for polyether polyurethane-induced angiogenesis in mice","volume":"34","author":"Figueiredo","year":"2019","journal-title":"Histol. Histopathol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37523_bib34","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm.2537","article-title":"Tumor angiogenesis: molecular pathways and therapeutic targets","volume":"17","author":"Weis","year":"2011","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37523_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13402-014-0216-2","article-title":"Chlorogenic acid inhibits hypoxia-induced angiogenesis via down-regulation of the HIF-1\u03b1\/AKT pathway","volume":"38","author":"Park","year":"2015","journal-title":"Cell. Oncol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e37523_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.14254","article-title":"A review of the protective effects of chlorogenic acid against different chemicals","volume":"46","author":"Rashidi","year":"2022","journal-title":"J. Food Biochem."},{"issue":"15","key":"10.1016\/j.heliyon.2024.e37523_bib37","doi-asserted-by":"crossref","first-page":"8199","DOI":"10.3390\/ijms22158199","article-title":"Targeting DNA damage response and repair to enhance therapeutic index in cisplatin-based cancer treatment","volume":"22","author":"Kiss","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e37523_bib38","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1023\/A:1008209720526","article-title":"Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials","volume":"8","author":"Voldborg","year":"1997","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.heliyon.2024.e37523_bib39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.semcancer.2019.06.002","article-title":"Akt in cancer: mediator and more","volume":"59","author":"Revathidevi","year":"2019","journal-title":"Semin. Cancer Biol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37523_bib40","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc.2017.51","article-title":"Microenvironmental regulation of tumour angiogenesis","volume":"17","author":"Palma","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.heliyon.2024.e37523_bib41","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.biochi.2019.05.003","article-title":"Herbacetin suppressed MMP9 mediated angiogenesis of malignant melanoma through blocking EGFR-ERK\/AKT signaling pathway","volume":"162","author":"Li","year":"2019","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37523_bib42","first-page":"83","article-title":"Akt- and MAPK-mediated activation and secretion of MMP-9 into stroma in breast cancer cells upon heregulin treatment","volume":"1","author":"Cho","year":"2008","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37523_bib43","first-page":"602","article-title":"Chlorogenic acid intake guidance: sources, health benefits, and safety","volume":"31","author":"Yu","year":"2022","journal-title":"Asia Pac. J. Clin. Nutr."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37523_bib44","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1111\/1541-4337.12620","article-title":"Chlorogenic acid: a comprehensive review of the dietary sources, processing effects, bioavailability, beneficial properties, mechanisms of action, and future directions","volume":"19","author":"Lu","year":"2020","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"10.1016\/j.heliyon.2024.e37523_bib45","article-title":"Chlorogenic acid inhibits glioblastoma growth through repolarizating macrophage from M2 to M1 phenotype","volume":"7","author":"Xue","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37523_bib46","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1080\/01635581.2010.492083","article-title":"Antiproliferation effect of commercially brewed coffees on human ovarian cancer cells in vitro","volume":"62","author":"Tai","year":"2010","journal-title":"Nutr. Cancer"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e37523_bib47","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/life11090950","article-title":"Hesperidin and chlorogenic acid synergistically inhibit the growth of breast cancer cells via estrogen receptor\/mitochondrial pathway","volume":"11","author":"Hsu","year":"2021","journal-title":"Life"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024135542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024135542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:24:07Z","timestamp":1790713447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024135542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":47,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2405844024135542"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37523","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chlorogenic acid exhibits antitumor effect in patient-derived xenograft models and hydrogel-embedded tissue culture drug susceptibility test of tongue cancer","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37523","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e37523"}}